108 related articles for article (PubMed ID: 36163218)
1. Nonalcoholic fatty liver disease and risk of intracerebral hemorrhage.
Wu J; Guo J; Wang A; Zhang Y; Wu S; Liu Y; Zhao X
Nutr Metab Cardiovasc Dis; 2022 Nov; 32(11):2561-2567. PubMed ID: 36163218
[TBL] [Abstract][Full Text] [Related]
2. Lack of association between nonalcoholic fatty liver disease and intracerebral hemorrhage: A community-based cohort study.
Wu J; Guo J; Wang A; Zhang Y; Wu S; Zhao X
J Clin Neurosci; 2023 Dec; 118():7-11. PubMed ID: 37832266
[TBL] [Abstract][Full Text] [Related]
3. Severity of Nonalcoholic Fatty Liver Disease and Risk of Future Ischemic Stroke Events.
Xu J; Dai L; Zhang Y; Wang A; Li H; Wang Y; Meng X; Wu S; Wang Y
Stroke; 2021 Jan; 52(1):103-110. PubMed ID: 33272125
[TBL] [Abstract][Full Text] [Related]
4. Severity of Nonalcoholic Fatty Liver Disease is Associated With Cardiovascular Outcomes in Patients With Prehypertension or Hypertension: A Community-Based Cohort Study.
Song QR; Liu SL; Ling QH; Gao QN; Yang RX; Chen SH; Wu SL; Chen ML; Cai J
Front Endocrinol (Lausanne); 2022; 13():942647. PubMed ID: 36093080
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease and risk of incident young-onset hypertension: Effect modification by sex.
Kim Y; Chang Y; Ryu S; Park S; Cho Y; Sohn W; Kang J; Wild SH; Byrne CD
Nutr Metab Cardiovasc Dis; 2023 Aug; 33(8):1608-1616. PubMed ID: 37357078
[TBL] [Abstract][Full Text] [Related]
6. Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus.
Cho HJ; Hwang S; Park JI; Yang MJ; Hwang JC; Yoo BM; Lee KM; Shin SJ; Lee KJ; Kim JH; Cheong JY; Cho SW; Kim SS
Gut Liver; 2019 Apr; 13(4):440-449. PubMed ID: 30970431
[TBL] [Abstract][Full Text] [Related]
7. Transient remission of nonalcoholic fatty liver disease decreases the risk of incident type 2 diabetes mellitus in Japanese men.
Fukuda T; Hamaguchi M; Kojima T; Mitsuhashi K; Hashimoto Y; Ohbora A; Kato T; Nakamura N; Fukui M
Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1443-1449. PubMed ID: 27603300
[TBL] [Abstract][Full Text] [Related]
8. The preventive effect of sustained physical activity on incident nonalcoholic fatty liver disease.
Kwak MS; Kim D; Chung GE; Kim W; Kim JS
Liver Int; 2017 Jun; 37(6):919-926. PubMed ID: 27917585
[TBL] [Abstract][Full Text] [Related]
9. Association between Non-Alcoholic Fatty Liver Disease and Intracerebral Hemorrhage.
Tu S; Zhao R; Fang H; Wang L; Shao A; Sheng J
Cell Transplant; 2019 Aug; 28(8):1033-1038. PubMed ID: 30922067
[TBL] [Abstract][Full Text] [Related]
10. Fasting Ketonuria and the Risk of Incident Nonalcoholic Fatty Liver Disease With and Without Liver Fibrosis in Nondiabetic Adults.
Kim Y; Chang Y; Kwon MJ; Hong YS; Kim MK; Sohn W; Cho YK; Shin H; Wild SH; Byrne CD; Ryu S
Am J Gastroenterol; 2021 Nov; 116(11):2270-2278. PubMed ID: 34114568
[TBL] [Abstract][Full Text] [Related]
11. Severity of non-alcoholic fatty liver disease is a risk factor for developing hypertension from prehypertension.
Song Q; Ling Q; Fan L; Deng Y; Gao Q; Yang R; Chen S; Wu S; Cai J
Chin Med J (Engl); 2023 Jul; 136(13):1591-1597. PubMed ID: 37027402
[TBL] [Abstract][Full Text] [Related]
12. The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study.
Park J; Kim G; Kim BS; Han KD; Kwon SY; Park SH; Lee YB; Jin SM; Kim JH
Cardiovasc Diabetol; 2022 Apr; 21(1):53. PubMed ID: 35429980
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.
Wang X; Wu S; Yuan X; Chen S; Fu Q; Sun Y; Lan Y; Hu S; Wang Y; Lu Y; Qu S; Wang L
J Clin Endocrinol Metab; 2022 Jan; 107(2):e745-e755. PubMed ID: 34467980
[TBL] [Abstract][Full Text] [Related]
14. The associations between changes in hepatic steatosis and heart failure and mortality: a nationwide cohort study.
Park J; Kim G; Kim H; Lee J; Jin SM; Kim JH
Cardiovasc Diabetol; 2022 Dec; 21(1):287. PubMed ID: 36564787
[TBL] [Abstract][Full Text] [Related]
15. Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease.
Ahn JM; Paik YH; Min SY; Cho JY; Sohn W; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Gut Liver; 2016 Mar; 10(2):295-302. PubMed ID: 26347511
[TBL] [Abstract][Full Text] [Related]
16. Short sleep duration is a risk of incident nonalcoholic fatty liver disease: a population-based longitudinal study.
Okamura T; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
J Gastrointestin Liver Dis; 2019 Mar; 28(1):73-81. PubMed ID: 30851175
[TBL] [Abstract][Full Text] [Related]
17. Effect of longitudinal changes of body fat on the incidence and regression of nonalcoholic fatty liver disease.
Kim D; Chung GE; Kwak MS; Kim YJ; Yoon JH
Dig Liver Dis; 2018 Apr; 50(4):389-395. PubMed ID: 29373238
[TBL] [Abstract][Full Text] [Related]
18. Radiologic evaluation of nonalcoholic fatty liver disease.
Lee SS; Park SH
World J Gastroenterol; 2014 Jun; 20(23):7392-402. PubMed ID: 24966609
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of the changes in hepatic steatosis status on the risk of incident type 2 diabetes mellitus: A 15-year community-based prospective cohort study.
Chung SM; Kang MK; Jung J; Yoon JS; Won KC; Lee HW; Loomba R; Park JG; Moon JS
Diabetes Res Clin Pract; 2022 Feb; 184():109208. PubMed ID: 35063496
[TBL] [Abstract][Full Text] [Related]
20. Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis.
Sinn DH; Cho SJ; Gu S; Seong D; Kang D; Kim H; Yi BK; Paik SW; Guallar E; Cho J; Gwak GY
Gastroenterology; 2016 Sep; 151(3):481-488.e1. PubMed ID: 27283259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
